Page 7 - Tim Stenzel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The agency's announcement Tuesday is aimed at making it easier to screen Americans returning to school and work, senior FDA regulators said.

The slow process to getting rapid COVID-19 tests approved by the FDA Published: February 26, 2021 5:31 PM EST Updated: February 26, 2021 6:05 PM EST Recommended A top national scientist speaks out against the FDA, saying the agency is too slow to push out new COVID-19 tests leading to outbreaks and costing us lives. Now, the FDA responds. When the pandemic began, Owen Kaye-Kauderer and his team knew how to help. Kaye-Kauderer is the Cofounder and Chief Business Officer of Detect. “That meant building the test that we knew that was needed, which was a home test that was accurate, and fast an...

POLITICO Get the Prescription Pulse newsletter Email Sign Up By signing up you agree to receive email newsletters or updates from POLITICO and you agree to our privacy policy and terms of service. You can unsubscribe at any time and you can contact us here. This sign-up form is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. Presented by Coalition for Affordable Prescription Drugs With Emily Martin — Congress waits on FDA pick as Senate readies for the first HHS confirmation hearing. — FDA device panel meets today to discuss drug-coated balloon. It’s W...

Biden health team hatches new vaccine strategy as variant threat builds POLITICO 2/5/2021 © Michael Ciaglo/Getty Images Pharmacy technicians prepare doses of the Covid-19 vaccine. The Food and Drug Administration is preparing to release new standards for Covid-19 vaccine booster shots, tests and drugs in the coming weeks — all aimed at preparing the country to beat back fast-spreading virus variants that are less susceptible to existing shots. The agency confirmed Thursday that it plans to release draft guidance. It could come in two to three weeks, according to four people familiar wi...

Copy shortlink: The U.S. Food and Drug Administration is alerting lab managers that several COVID-19 tests, including one used in Minnesota's free public testing, carry a slight risk of returning inaccurate results because of recent genetic mutations in the virus. But there's an upside. Thermo Fisher Scientific, which makes the TaqPath COVID test used at community testing sites across the state, says the test not only remains accurate, but it may offer an important clue that a more infectious COVID strain is present. And the technique has already worked in Minnesota. D...